October 2016 – Page 3 – Policy & Medicine

EFPIA HCP Financial Disclosure Is Not Risk Free

MACRA Final Rule to Be Released Today – Promises to Bring a New Level of Transparency

What You Don’t Know About AMP Can Hurt You – Part 3 Can You Defend Your AMP?

HHS Issues Open Government Plan

Mylan Reaches Deal Over EpiPen Rebates

Getting to the Hub of the Matter: Analyzing the Compliance Needs for Hub Services

FDA Issues Draft Guidance on Real-World Data

The Debate Rages On: Should Clinical Trial Data Be Public?

Biosimilar User Fee Act (II) Performance Goals Letter Issued

FDA Announces Draft MDUFA Agreement